Eosinophilic Disorders — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Eosinophilic Disorders.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Eosinophilic Disorders and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Sanap SS, Gupta KR, Kabra UD, Umekar MJ Precision medicine in asthma: endotype stratification, biomarker-guided biologics, and emerging therapeutic strategies Mol Biol Rep, 2026.PMID 42467299
[2]Utami FA, Huang SY, Liu YH, Hsu JW, et al. Aspartame and asthma: immunomodulatory effects on airway inflammation Respir Res, 2026.PMID 42464261
[3]Al-Rusan O, Shen Q, Medeiros LJ From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma Ann Diagn Pathol, 2026.PMID 42462588
[4]Votto M, Olcese R, De Filippo M, Caminiti L, et al. Gastrointestinal manifestations during oral immunotherapy: A guide for pediatric allergists Pediatr Allergy Immunol, 2026.PMID 42430571
[5]Arora S, Dellon ES Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis Annu Rev Med, 2026.PMID 42361381
[6]Dash M, Ayub A, Vasudevan B, Sood A Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study Allergy Asthma Proc, 2026.PMID 42343500
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Eosinophilic Disorders and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Sanap SS, Gupta KR, Kabra UD, Umekar MJ Precision medicine in asthma: endotype stratification, biomarker-guided biologics, and emerging therapeutic strategies Mol Biol Rep, 2026.PMID 42467299
[2]Utami FA, Huang SY, Liu YH, Hsu JW, et al. Aspartame and asthma: immunomodulatory effects on airway inflammation Respir Res, 2026.PMID 42464261
[3]Al-Rusan O, Shen Q, Medeiros LJ From the archives of MD Anderson Cancer Center: Crystal-storing histiocytosis associated with B-cell lymphoma Ann Diagn Pathol, 2026.PMID 42462588
[4]Votto M, Olcese R, De Filippo M, Caminiti L, et al. Gastrointestinal manifestations during oral immunotherapy: A guide for pediatric allergists Pediatr Allergy Immunol, 2026.PMID 42430571
[5]Arora S, Dellon ES Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis Annu Rev Med, 2026.PMID 42361381
[6]Dash M, Ayub A, Vasudevan B, Sood A Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study Allergy Asthma Proc, 2026.PMID 42343500
[7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922